These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31275142)

  • 1. Target Identification of Active Constituents of
    Zhang JY; Hong CL; Chen HS; Zhou XJ; Zhang YJ; Efferth T; Yang YX; Li CY
    Front Pharmacol; 2019; 10():650. PubMed ID: 31275142
    [No Abstract]   [Full Text] [Related]  

  • 2. The Effect of Shen Qi Wan Medicated Serum on NRK-52E Cells Proliferation and Migration by Targeting Aquaporin 1 (AQP1).
    He Y; Bao YT; Chen HS; Chen YT; Zhou XJ; Yang YX; Li CY
    Med Sci Monit; 2020 Jun; 26():e922943. PubMed ID: 32491998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated Systems Pharmacology, Urinary Metabonomics, and Quantitative Real-Time PCR Analysis to Uncover Targets and Metabolic Pathways of the You-Gui Pill in Treating Kidney-Yang Deficiency Syndrome.
    Chen R; Wang J; Zhan R; Zhang L; Wang X
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic profiling reveals therapeutic biomarkers of processed Aconitum carmichaeli Debx in treating hydrocortisone induced kidney-yang deficiency syndrome rats.
    Tan Y; Liu X; Lu C; He X; Li J; Xiao C; Jiang M; Yang J; Zhou K; Zhang Z; Zhang W; Lu A
    J Ethnopharmacol; 2014 Mar; 152(3):585-93. PubMed ID: 24556226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on the substance basis of the efficacy of eucommiae cortex before and after salt processing for the treatment of kidney-yang deficiency syndrome based on the spectrum-effect relationship.
    Wu H; Lv Y; Zhao M; Tang R; Li Y; Fang K; Wei F; Ge W; Du W; Li C; Zhang Y
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116926. PubMed ID: 37479066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chinmedomics strategy to discover effective constituents and elucidate action mechanism of Nanshi capsule against kidney-yang deficiency syndrome].
    Liu Q; Zhao HW; Zhang AH; Sun H; Zhao XH; Nan Y; Kong L; Guan Y; Zou SY; Ma ZH; Wang XJ
    Zhongguo Zhong Yao Za Zhi; 2016 Aug; 41(15):2901-2914. PubMed ID: 28914036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the mechanism of Shen Qi Wan prescription in the treatment of T2DM via network pharmacology and molecular docking.
    Zhao P; Zhang X; Gong Y; Li W; Wu Z; Tang Y; Liu G
    In Silico Pharmacol; 2022; 10(1):9. PubMed ID: 35673584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel chinmedomics strategy for discovering effective constituents from ShenQiWan acting on ShenYangXu syndrome.
    Zhou XH; Zhang AH; Wang L; Tan YL; Guan Y; Han Y; Sun H; Wang XJ
    Chin J Nat Med; 2016 Aug; 14(8):561-81. PubMed ID: 27608946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the mechanism of physcion-1-O-β-D-monoglucoside against acute lymphoblastic leukaemia based on network pharmacology and experimental validation.
    Liu J; Yang Y; Zeng Y; Qin X; Guo L; Liu W
    Heliyon; 2023 Mar; 9(3):e14009. PubMed ID: 36923879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Protective Effect of Shen Qi Wan on Adenine-Induced Podocyte Injury.
    Lin Y; Zhang J; Fu Y; Ji L; Lin L; Chen H; Yang Y; Li C
    Evid Based Complement Alternat Med; 2020; 2020():5803192. PubMed ID: 33273954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of
    Zhang L; Lang J; Jin L; Jin L; Cao B; Shao X; Fang M; Cai Y; Liu X; Fu H; Shou Q
    Evid Based Complement Alternat Med; 2020; 2020():5952612. PubMed ID: 32565866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shen Qi Wan ameliorates nephritis in chronic kidney disease via AQP1 and DEFB1 regulation.
    Liu Y; Hong X; Liu L; Li X; Huang S; Luo Q; Huang Q; Qiu J; Qiu P; Li C
    Biomed Pharmacother; 2024 Jan; 170():116027. PubMed ID: 38113630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network Pharmacology-Based Identification of the Mechanisms of Shen-Qi Compound Formula in Treating Diabetes Mellitus.
    Hu Z; Yang M; Yang L; Xie C; Gao H; Fu X; Xie H; Liu Y
    Evid Based Complement Alternat Med; 2020; 2020():5798764. PubMed ID: 32595730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis on targets of regulating Qi and activating blood based on activity spectrum of targets].
    Ma J; Ren Y; Zhang JN; Lin L; Zhang YL
    Zhongguo Zhong Yao Za Zhi; 2021 Aug; 46(15):3970-3979. PubMed ID: 34472274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-omics approaches revealed the therapeutic mechanisms of Suo-Quan-Wan for treating overactive bladder in spontaneously hypertensive rats.
    Sun Z; Tie Y; Tong X; Cheng M; Wu Y; Xu P; Xue M; Xu L; Zhou X
    J Ethnopharmacol; 2024 Jan; 318(Pt B):117066. PubMed ID: 37604331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research on the effect of Dipsaci Radix before and after salt-processed on kidney yang deficiency syndrome rats and the preliminary mechanism study through the BMP-Smad signaling pathway.
    Du W; Lv Y; Wu H; Li Y; Tang R; Zhao M; Wei F; Li C; Ge W
    J Ethnopharmacol; 2023 Aug; 312():116480. PubMed ID: 37061069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
    Chen R; Wang J; Zhan R; Zhang L; Wang X
    J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. iTRAQ-Based Proteomics to Reveal the Mechanism of Hypothalamus in Kidney-Yin Deficiency Rats Induced by Levothyroxine.
    Guan W; Liu Y; Li X; Yang B; Kuang H
    Evid Based Complement Alternat Med; 2019; 2019():3703596. PubMed ID: 30949216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network Pharmacology-Based Approach to Comparatively Predict the Active Ingredients and Molecular Targets of Compound Xueshuantong Capsule and Hexuemingmu Tablet in the Treatment of Proliferative Diabetic Retinopathy.
    Yao H; Xin D; Zhan Z; Li Z
    Evid Based Complement Alternat Med; 2021; 2021():6642600. PubMed ID: 33747106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the biomarkers and therapeutic mechanism of kidney-yang deficiency syndrome treated by You-gui pill using systems pharmacology and serum metabonomics.
    Chen R; Wang J; Liao C; Zhang L; Guo Q; Wang X
    RSC Adv; 2018 Jan; 8(2):1098-1115. PubMed ID: 35539000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.